Erik Wallstroem

1.4k citations
20 papers · 1.0k indexed · 2 hit papers · h-index 8

Impact in

Papers in

Erik Wallstroem

20 papers receiving 1.0k citations

Hit Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis 2025 · 26 citations
262000202620082017200400600

Peers

Erik Wallstroem
Comparison fields: 5 of 77
  • Developmental Neuroscience 243
  • Pathology and Forensic Medicine 636
  • Neurology 276
  • Neurology 217
  • Immunology 276
Replace Daniele Carassiti with:
Daniele Carassiti United Kingdom
Mark Marriott Australia
John Parratt Australia
Uschi Brehm Germany
Anja Moldenhauer Germany
Virginia Van Keulen United States
Takaaki Ishizu Japan
Maciej Juryńczyk United Kingdom
C. Bash United States
Shuhei Nishiyama Japan
Erik Wallstroem relative to Daniele Carassiti United Kingdom Daniele Carassiti's profile →
Citations per field
00.5×1.5×
Daniele Carassiti · 1×
Citations per year

Countries citing papers authored by Erik Wallstroem

Since Specialization
Citations

This map shows the geographic impact of Erik Wallstroem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Wallstroem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Wallstroem more than expected).

Fields of papers citing papers by Erik Wallstroem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Wallstroem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Wallstroem. The network helps show where Erik Wallstroem may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Erik Wallstroem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erik Wallstroem Line = papers co-authored together Erik Wallstroem links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
Hit paper breakdown →
202526
2 202514
3 20252
4 20251
5 202434
6 20246
7 20241
8 20246
9 202410
10 202312
11 20232
12 20215
13 20175
14 20171
15 20163
16 20161
17 2016163
18 20157
19 20134
20
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Hit paper breakdown →
2000727

About Erik Wallstroem

Erik Wallstroem is a scholar working on Pathology and Forensic Medicine, Neurology, Immunology, Genetics and Hematology, having authored 20 papers that have together received 1.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (5 papers), Myasthenia Gravis and Thymoma (3 papers), Hereditary Neurological Disorders (3 papers), Immunotherapy and Immune Responses (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Polyomavirus and related diseases (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Developmental Neuroscience (243 citations), Pathology and Forensic Medicine (636 citations), Neurology (276 citations), Neurology (217 citations) and Immunology (276 citations). Erik Wallstroem has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Andreas Stefferl, Maria K. Storch, Tomas Olsson, Manfred Schmidbauer, Christopher Linington, Hans Lassmann, Robert Weissert, Barbara Kornek, Eva Havrdová and A. Wright. Their work appears in journals such as Neurology, Multiple Sclerosis and Related Disorders, New England Journal of Medicine, Journal of the Peripheral Nervous System and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026